Try our Advanced Search for more refined results

United States of America et al v. Bristol Myers Squibb Company et al

Track this case

Case Number:

3:13-cv-01039

Court:

Nature of Suit:

Other Statutory Actions

Judge:

Freda L. Wolfson

Firms

Companies

Bristol-Myers Squibb Co.

Sectors & Industries:

Healthcare
- Major

June 27, 2017
BMS, Sanofi Escape Plavix FCA Suit Under Escobar Standard

Bristol-Myers Squibb and Sanofi have escaped a whistleblower False Claims Act suit accusing them of prompting Medicaid overbilling through deceptive marketing of the blood thinner Plavix, after a New Jersey federal judge ruled Tuesday that automatic payment requirements made any implied certifications regarding the drug's effectiveness immaterial to payment.
June 29, 2016
Plavix FCA Suit Revived After High Court's Escobar Ruling

A New Jersey federal judge on Wednesday reopened a False Claims Act suit against Sanofi-Aventis US LLC and Bristol-Myers Squibb Co. following the U.S. Supreme Court's recent Escobar ruling that liability under the statute can be triggered by failure to comply with regulations that aren't explicit conditions of payment.
December 16, 2015
NJ Plavix Suit Stayed Pending Supreme Court FCA Ruling

A New Jersey federal judge on Wednesday paused a False Claims Act accusing Sanofi-Aventis US LLC and Bristol-Myers Squibb Co. of deceptively pushing the blood thinner Plavix, pending a U.S. Supreme Court decision in a case over the so-called implied certification theory.
August 20, 2015
NJ Judge Trims Sales Rep's FCA Claims In Plavix MDL

A New Jersey judge on Thursday stripped Medicare and Medicaid claims involving 33 states from the False Claims Act suit of a former Sanofi-Aventis US LLC sales representative accusing the drugmaker and Bristol-Myers Squibb Co. of deceptively pushing the blood thinner Plavix.